Belden
BDC
92.79
-7.25
-7.25%
Belden
US · BDC
#2220 by market cap
Listed 1970
92.79
-7.25
-7.25%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.79, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +10.33% YoY
Margins
- Gross margin
- 37.98%
- Operating margin
- 11.63%
- Net margin
- 8.75%
Key ratios & quality
- Enterprise valuei
- 4.55B
- Altman Z-Scorei
- 2.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.17B | 2.13B | 1.75B | 2.30B | 2.61B | 2.51B | 2.46B | 2.72B |
| Gross profit | 829.91M | 793.51M | 575.62M | 771.84M | 916.29M | 954.97M | 922.22M | 1.03B |
| Selling & admin expenses | 411.35M | 417.33M | 323.45M | 378.03M | 448.64M | 492.70M | 494.60M | 533.37M |
| Research & development | 91.55M | 94.36M | 73.02M | 90.23M | 104.35M | 116.43M | 112.37M | 128.76M |
| Operating profit | 251.87M | 207.21M | 150.11M | 272.96M | 325.44M | 305.46M | 266.46M | 315.69M |
| Pretax profit | 230.08M | 152.41M | 90.82M | 226.78M | 317.39M | 285.76M | 227.94M | 266.87M |
| Tax | 62.94M | 42.52M | 20.10M | 27.94M | 49.65M | 43.20M | 29.53M | 29.34M |
| Net profit | 160.71M | -376.78M | -55.06M | 64.32M | 254.82M | 242.56M | 198.41M | 237.52M |
| Basic EPS | 3 | -9 | -1 | 1 | 6 | 6 | 5 | 6 |
| Diluted EPS | 3.07 | -9.37 | -1.23 | 1.41 | 5.72 | 5.66 | 4.80 | 5.91 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 671.99M | 698.22M | 720.12M | 696.38M | 750.16M | 965.95M |
| Gross profit | 258.57M | 263.20M | 263.57M | 258.09M | 293.62M | 338.75M |
| Selling & admin expenses | 131.92M | 139.42M | 130.51M | 138.65M | 147.83M | 211.96M |
| Research & development | 33.94M | 33.86M | 32.54M | 30.09M | 31.71M | 55.22M |
| Operating profit | 79.24M | 76.29M | 87.54M | 77.96M | 99.26M | 16.76M |
| Pretax profit | 66.67M | 64.25M | 73.86M | 62.77M | 85.21M | -25.53M |
| Tax | 5.67M | 7.56M | 5.97M | 11.74M | 16.67M | -14.18M |
| Net profit | 61.01M | 56.69M | 67.89M | 51.03M | 68.54M | -11.35M |
| Basic EPS | 2 | 1 | 2 | 1 | 2 | 0 |
| Diluted EPS | 1.53 | 1.41 | 1.70 | 1.30 | 1.74 | -0.29 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.26B | 1.38B | 1.10B | 1.88B | 1.54B | 1.46B | 1.20B | 1.35B |
| Cash & ST investments | 407.45M | 407.48M | 501.99M | 641.56M | 687.68M | 597.04M | 370.30M | 389.89M |
| Inventory | 265.00M | 231.33M | 247.30M | 345.20M | 341.56M | 366.99M | 343.10M | 402.35M |
| Total assets | 3.78B | 3.41B | 3.14B | 3.42B | 3.16B | 3.24B | 3.33B | 3.54B |
| Total current liabilities | 716.92M | 722.54M | 520.76M | 752.87M | 639.92M | 633.50M | 622.70M | 697.50M |
| Short-term debt | -- | 14.07M | 14.84M | 16.52M | 16.83M | 18.95M | 21.09M | 22.15M |
| Long-term debt | 1.46B | 1.44B | 1.57B | 1.46B | 1.16B | 1.20B | 1.13B | 1.29B |
| Total liabilities | 2,391,733,000.00 | 2,440,940,000.00 | 2,382,683,000.00 | 2,461,595,000.00 | 2,017,725,000.00 | 2,073,889,000.00 | 2,033,202,000.00 | 2,279,197,000.00 |
| Total equity | 1.39B | 965.82M | 757.05M | 956.08M | 1.14B | 1.17B | 1.29B | 1.26B |
| Retained earnings | 922.00M | 518.00M | 450.88M | 505.72M | 751.52M | 985.81M | 1.18B | 1.41B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 1.22B | 1.26B | 1.35B | 1.28B | 1.39B | 1.73B |
| Cash & ST investments | 301.49M | 314.26M | 389.89M | 272.15M | 348.66M | 380.71M |
| Inventory | 388.79M | 393.91M | 402.35M | 423.12M | 420.59M | 555.07M |
| Total assets | 3.40B | 3.44B | 3.54B | 3.46B | 3.57B | 5.97B |
| Total current liabilities | 615.59M | 631.45M | 697.50M | 613.63M | 652.79M | 951.32M |
| Short-term debt | -- | -- | 22.15M | -- | -- | 18.50M |
| Long-term debt | 1.27B | 1.28B | 1.29B | 1.26B | 1.23B | 3.03B |
| Total liabilities | 2,165,182,000.00 | 2,194,728,000.00 | 2,279,197,000.00 | 2,176,423,000.00 | 2,182,802,000.00 | 4,575,223,000.00 |
| Total equity | 1.23B | 1.24B | 1.26B | 1.28B | 1.38B | 1.39B |
| Retained earnings | 1.28B | 1.34B | 1.41B | 1.45B | 1.52B | 1.51B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 289.22M | 276.89M | 173.36M | 272.06M | 281.30M | 319.64M | 352.08M | 354.86M |
| Depreciation & amortization | 148.63M | 139.26M | 108.69M | 87.99M | 88.74M | 99.45M | 115.74M | 129.43M |
| Free cash flow | 191.37M | 166.89M | 83.15M | 177.42M | 176.20M | 202.91M | 222.98M | 218.69M |
| Dividends paid | -43.17M | -34.44M | -9.03M | -9.06M | -8.95M | -8.50M | -8.20M | -7.97M |
| Stock buybacks / issuance | -175.00M | -50.00M | -35.00M | 0 | -146.28M | -185.57M | -125.39M | -183.96M |
| Ending cash balance | 420.61M | 425.89M | 501.99M | 643.76M | 687.68M | 597.04M | 370.30M | 389.89M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 82.03M | 105.01M | 160.39M | -18.67M | 129.22M | 129.64M |
| Depreciation & amortization | 32.07M | 33.56M | 34.02M | 32.46M | 36.10M | 78.39M |
| Free cash flow | 56.88M | 65.33M | 121.25M | -63.06M | 88.56M | 81.83M |
| Dividends paid | -2.01M | -1.98M | -1.97M | -1.97M | -1.95M | -1.95M |
| Stock buybacks / issuance | -16.48M | -42.19M | -44.62M | -25.69M | -1.43M | 8.92M |
| Ending cash balance | 301.49M | 314.26M | 389.89M | 272.15M | 348.66M | 380.71M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.93 | -33.70 | -6.45 | 7.49 | 24.27 | 21.02 | 16.13 | 18.56 |
| ROA %i | 3.31 | -11.01 | -1.69 | 1.95 | 7.74 | 7.58 | 6.04 | 6.91 |
| ROIC %i | 5.85 | -13.32 | -0.28 | 4.44 | 11.94 | 11.20 | 9.25 | 10.70 |
| 5-year avg ROE %i | 8.00 | -0.55 | -3.47 | -3.94 | 0.11 | 2.53 | 12.49 | 17.50 |
| EBIT margin %i | 10.90 | 9.77 | 6.71 | 6.24 | 13.85 | 12.71 | 10.82 | 11.54 |
| FCF / sales %i | 7.40 | 7.83 | 4.46 | 7.37 | 6.76 | 8.08 | 9.06 | 8.05 |
| Current ratioi | 1.76 | 1.91 | 2.11 | 2.49 | 2.40 | 2.30 | 1.92 | 1.93 |
| Quick ratioi | 1.04 | 1.03 | 1.53 | 1.36 | 1.76 | 1.60 | 1.25 | 1.22 |
| Debt / assetsi | 38.72 | 44.30 | 52.07 | 45.02 | 39.13 | 40.06 | 37.60 | 39.57 |
| LT debt / equityi | 105.48 | 155.77 | 215.85 | 159.32 | 106.77 | 109.68 | 95.01 | 109.14 |
| Interest coveragei | 4.58 | 3.73 | 2.12 | 2.40 | 8.29 | 9.50 | 6.95 | 6.76 |
| Revenue CAGR (3Y) %i | -2.12 | -3.30 | -5.66 | 2.04 | 6.94 | 12.76 | 2.26 | 1.37 |
| Net income CAGR (3Y) %i | 34.45 | -- | -- | -26.48 | -- | -- | 45.88 | -2.30 |
| FCF CAGR (3Y) %i | 0.87 | -13.83 | -24.22 | -2.49 | 1.83 | 34.63 | 7.92 | 7.47 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 18.34 | 18.41 | 18.56 | 18.89 | 18.64 | 13.37 |
| ROA %i | 6.50 | 6.73 | 6.91 | 7.03 | 7.01 | 3.75 |
| ROIC %i | 10.38 | 10.36 | 10.70 | 10.94 | 10.85 | 6.93 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.27 | 11.09 | 11.54 | 11.39 | 11.77 | 8.86 |
| FCF / sales %i | 8.24 | 8.04 | 8.05 | 6.47 | 7.40 | 7.30 |
| Current ratioi | 1.99 | 1.99 | 1.93 | 2.09 | 2.14 | 1.82 |
| Quick ratioi | 1.23 | 1.23 | 1.22 | 1.26 | 1.35 | 1.12 |
| Debt / assetsi | 40.25 | 40.03 | 39.57 | 39.03 | 36.98 | 53.02 |
| LT debt / equityi | 110.83 | 110.76 | 109.14 | 105.24 | 95.28 | 225.98 |
| Interest coveragei | 6.70 | 6.60 | 6.76 | 6.38 | 6.60 | 3.41 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Belden discussion 0 comments